BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $755,000 | +273.8% | 13,348 | +275.4% | 0.00% | – |
Q4 2019 | $202,000 | -14.4% | 3,556 | -19.6% | 0.00% | – |
Q3 2019 | $236,000 | -95.3% | 4,422 | -94.8% | 0.00% | -100.0% |
Q2 2019 | $5,048,000 | +319.6% | 84,537 | +338.0% | 0.01% | +300.0% |
Q1 2019 | $1,203,000 | -5.4% | 19,300 | -8.0% | 0.00% | 0.0% |
Q4 2018 | $1,272,000 | -19.5% | 20,989 | -40.4% | 0.00% | 0.0% |
Q2 2018 | $1,580,000 | +44.8% | 35,212 | +43.1% | 0.00% | +100.0% |
Q1 2018 | $1,091,000 | +58.1% | 24,611 | +54.7% | 0.00% | 0.0% |
Q4 2017 | $690,000 | +74.2% | 15,913 | +86.8% | 0.00% | 0.0% |
Q3 2017 | $396,000 | +93.2% | 8,517 | +105.7% | 0.00% | – |
Q2 2017 | $205,000 | -70.0% | 4,140 | -78.9% | 0.00% | -100.0% |
Q1 2016 | $683,000 | +187.0% | 19,610 | +254.2% | 0.00% | +100.0% |
Q4 2015 | $238,000 | -54.7% | 5,537 | -58.7% | 0.00% | 0.0% |
Q1 2015 | $525,000 | +69.4% | 13,400 | +66.9% | 0.00% | 0.0% |
Q4 2014 | $310,000 | +11.9% | 8,031 | -21.8% | 0.00% | 0.0% |
Q2 2014 | $277,000 | – | 10,265 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 385,954 | $16,723,000 | 10.02% |
JW Asset Management, LLC | 73,649 | $3,191,000 | 3.40% |
Elk Creek Partners, LLC | 168,714 | $7,310,000 | 0.43% |
NORTHPOINTE CAPITAL LLC | 80,710 | $3,497,000 | 0.39% |
Ativo Capital Management LLC | 33,096 | $1,434,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 155,318 | $6,730,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 17,406 | $754,000 | 0.20% |
Matarin Capital Management, LLC | 48,952 | $2,121,090,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 4,324 | $187,000 | 0.05% |
Summit Trail Advisors, LLC | 6,797 | $295,000 | 0.04% |